← Insider buys
APRE

Aprea Therapeutics, Inc. · Healthcare

SVP and Chief Business Officer Gregory Alan Korbel sold $109K of Aprea Therapeutics, Inc.

Sold$108,900
$3.96Price
27,500Shares
−62%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Wed, Dec 1. Filed Fri, Dec 3, 12:01 PM ET, during the session. Not investment advice.